Study demonstrates seasonality of coronaviruses, IDSA publishes COVID-19 guidelines — top stories in infectious disease
Click Here to Manage Email Alerts
Healio spoke with Arnold S. Monto, MD, Thomas Francis, Jr. Collegiate Professor of Public Health at the University of Michigan School of Public Health, about his analysis on the seasonality of four different coronaviruses over an 8-year period. It was the top story in infectious disease last week.
Another top story was about the Infectious Diseases Society of America’s new guidelines on the treatment and management of patients with COVID-19.
Read these and more top stories in infectious disease below:
8-year study shows coronaviruses have ‘sharp seasonality’
An analysis of four different coronaviruses over an 8-year period demonstrated that they were detected in a limited timeframe, from December to April and May, with a peak during January and February, according to a recent study published in Journal of Infectious Diseases. Read more.
IDSA publishes ‘living guidelines’ on treatment of COVID-19
The Infectious Diseases Society of America published rapid guidelines on the treatment and management of patients with COVID-19 that mostly recommend recruiting patients into ongoing trials for investigational therapies. Read more.
Clinicians work through many unknowns, ever-changing information to care for COVID-19 survivors
As of April 15, nearly 2 million confirmed cases and more than 126,000 deaths in 213 countries and territories worldwide had been reported in the COVID-19 pandemic, according to WHO. However, in spite of these increases that are widely reported, many people are being discharged from hospitals and making a full recovery. Read more.
Trump’s plan to halt funding for WHO draws widespread criticism
President Donald J. Trump said Tuesday that the United States will halt funding for WHO, citing concerns regarding the agency’s relationship with China and its criticism of the president’s implementation of travel bans early in the COVID-19 pandemic. Read more.
FDA authorizes process it says could decontaminate 4 million masks daily
Amid widespread shortages of personal protective equipment and masks during the COVID-19 pandemic, the FDA has granted several emergency use authorizations for the decontamination and reuse of N95 or N95-equivilent masks. Read more.